{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:10:09Z","timestamp":1772507409556,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573922"],"award-info":[{"award-number":["81573922"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hubei province technical innovation project","award":["2017ACA176"],"award-info":[{"award-number":["2017ACA176"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017ZC0135"],"award-info":[{"award-number":["2017ZC0135"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Elite Youth Education Program of Guangzhou University of Chinese Medicine","award":["QNYC20140104"],"award-info":[{"award-number":["QNYC20140104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11064-018-2609-5","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T09:34:38Z","timestamp":1536658478000},"page":"1914-1926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Glycyrrhizic Acid Alleviates 6-Hydroxydopamine and Corticosterone-Induced Neurotoxicity in SH-SY5Y Cells Through Modulating Autophagy"],"prefix":"10.1007","volume":"43","author":[{"given":"Guangyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"issue":"12","key":"2609_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","volume":"13","author":"L Marsh","year":"2013","unstructured":"Marsh L (2013) Depression and Parkinson\u2019s disease: current knowledge. Curr Neurol Neurosci Rep 13(12):409. \n                    https:\/\/doi.org\/10.1007\/s11910-013-0409-5","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"7\u20138","key":"2609_CR2","first-page":"229","volume":"67","author":"Z Rihmer","year":"2014","unstructured":"Rihmer Z, Gonda X, Dome P (2014) Depression in Parkinson\u2019s disease. Ideggyogyaszati szemle 67(7\u20138):229\u2013236","journal-title":"Ideggyogyaszati szemle"},{"issue":"5","key":"2609_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/practneurol-2017-001650","volume":"17","author":"MHM Timmer","year":"2017","unstructured":"Timmer MHM, van Beek M, Bloem BR, Esselink RAJ (2017) What a neurologist should know about depression in Parkinson\u2019s disease. Pract Neurol 17(5):359\u2013368. \n                    https:\/\/doi.org\/10.1136\/practneurol-2017-001650","journal-title":"Pract Neurol"},{"issue":"4","key":"2609_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-0404.2006.00579.x","volume":"113","author":"L Ishihara","year":"2006","unstructured":"Ishihara L, Brayne C (2006) A systematic review of depression and mental illness preceding Parkinson\u2019s disease. Acta Neurol Scand 113(4):211\u2013220. \n                    https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00579.x","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2609_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","volume":"8","author":"D Aarsland","year":"2011","unstructured":"Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P (2011) Depression in Parkinson disease\u2013epidemiology, mechanisms and management. Nat Rev Neurol 8(1):35\u201347. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2011.189","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2609_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/JGP.0b013e3181e448f7","volume":"19","author":"RD Dobkin","year":"2011","unstructured":"Dobkin RD, Menza M, Bienfait KL, Gara M, Marin H, Mark MH, Dicke A, Friedman J (2011) Depression in Parkinson\u2019s disease: symptom improvement and residual symptoms after acute pharmacologic management. Am J Geriatr Psychiatry 19(3):222\u2013229. \n                    https:\/\/doi.org\/10.1097\/JGP.0b013e3181e448f7","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"2609_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13041-018-0356-9","volume":"11","author":"E Dalle","year":"2018","unstructured":"Dalle E, Mabandla MV (2018) Early life stress, depression and Parkinson\u2019s disease: a new approach. Mol Brain 11(1):18. \n                    https:\/\/doi.org\/10.1186\/s13041-018-0356-9","journal-title":"Mol Brain"},{"issue":"2","key":"2609_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1176\/appi.neuropsych.22.2.188","volume":"22","author":"RD Dobkin","year":"2010","unstructured":"Dobkin RD, Menza M, Bienfait KL, Gara M, Marin H, Mark MH, Dicke A, Troster A (2010) The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 22(2):188\u2013195. \n                    https:\/\/doi.org\/10.1176\/appi.neuropsych.22.2.188","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"7095","key":"2609_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441(7095):880\u2013884. \n                    https:\/\/doi.org\/10.1038\/nature04723","journal-title":"Nature"},{"key":"2609_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson\u2019s disease. Ann Rev Neurosci 28:57\u201387. \n                    https:\/\/doi.org\/10.1146\/annurev.neuro.28.061604.135718","journal-title":"Ann Rev Neurosci"},{"issue":"5646","key":"2609_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 302(5646):819\u2013822. \n                    https:\/\/doi.org\/10.1126\/science.1087753","journal-title":"Science"},{"issue":"1","key":"2609_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11481-012-9431-7","volume":"8","author":"TF Jiang","year":"2013","unstructured":"Jiang TF, Zhang YJ, Zhou HY, Wang HM, Tian LP, Liu J, Ding JQ, Chen SD (2013) Curcumin ameliorates the neurodegenerative pathology in A53T alpha-synuclein cell model of Parkinson\u2019s disease through the downregulation of mTOR\/p70S6K signaling and the recovery of macroautophagy. J Neuroimmune Pharmacol 8(1):356\u2013369. \n                    https:\/\/doi.org\/10.1007\/s11481-012-9431-7","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"2609_CR13","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1371\/journal.pbio.0060006","volume":"6","author":"M Sandal","year":"2008","unstructured":"Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, Musiani F, Brucale M, Bubacco L, Samori B (2008) Conformational equilibria in monomeric alpha-synuclein at the single-molecule level. PLoS Biol 6(1):e6. \n                    https:\/\/doi.org\/10.1371\/journal.pbio.0060006","journal-title":"PLoS Biol"},{"issue":"1","key":"2609_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/cr.2011.152","volume":"22","author":"E Wirawan","year":"2012","unstructured":"Wirawan E, Vanden Berghe T, Lippens S, Agostinis P, Vandenabeele P (2012) Autophagy: for better or for worse. Cell Res 22(1):43\u201361. \n                    https:\/\/doi.org\/10.1038\/cr.2011.152","journal-title":"Cell Res"},{"issue":"5","key":"2609_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1440-1819.2010.02135.x","volume":"64","author":"H Kunugi","year":"2010","unstructured":"Kunugi H, Hori H, Adachi N, Numakawa T (2010) Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin Neurosci 64(5):447\u2013459. \n                    https:\/\/doi.org\/10.1111\/j.1440-1819.2010.02135.x","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"2609_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jagp.2012.10.026","volume":"21","author":"Y Dwivedi","year":"2013","unstructured":"Dwivedi Y (2013) Involvement of brain-derived neurotrophic factor in late-life depression. Am J Geriatr Psychiatry 21(5):433\u2013449. \n                    https:\/\/doi.org\/10.1016\/j.jagp.2012.10.026","journal-title":"Am J Geriatr Psychiatry"},{"key":"2609_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2018.03.005","author":"Y Bai","year":"2018","unstructured":"Bai Y, Song L, Dai G, Xu M, Zhu L, Zhang W, Jing W, Ju W (2018) Antidepressant effects of magnolol in a mouse model of depression induced by chronic corticosterone injection. Steroids. \n                    https:\/\/doi.org\/10.1016\/j.steroids.2018.03.005","journal-title":"Steroids"},{"issue":"2","key":"2609_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbr.2005.11.019","volume":"168","author":"SA Johnson","year":"2006","unstructured":"Johnson SA, Fournier NM, Kalynchuk LE (2006) Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav Brain Res 168(2):280\u2013288. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2005.11.019","journal-title":"Behav Brain Res"},{"issue":"1\u20132","key":"2609_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","volume":"581","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Ma R, Shen J, Su H, Xing D, Du L (2008) A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 581(1\u20132):113\u2013120. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2007.12.005","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2609_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12640-015-9579-z","volume":"29","author":"S Ojha","year":"2016","unstructured":"Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME (2016) Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson\u2019s disease. Neurotox Res 29(2):275\u2013287. \n                    https:\/\/doi.org\/10.1007\/s12640-015-9579-z","journal-title":"Neurotox Res"},{"issue":"1","key":"2609_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJ (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener 12(1):10. \n                    https:\/\/doi.org\/10.1186\/s13024-017-0149-0","journal-title":"Mol Neurodegener"},{"key":"2609_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2017.04.063","volume":"651","author":"Y Hao","year":"2017","unstructured":"Hao Y, Shabanpoor A, Metz GA (2017) Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson\u2019s disease. Neurosci Lett 651:79\u201387. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2017.04.063","journal-title":"Neurosci Lett"},{"issue":"10","key":"2609_CR23","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.neurobiolaging.2011.11.025","volume":"33","author":"G Qiu","year":"2012","unstructured":"Qiu G, Spangler EL, Wan R, Miller M, Mattson MP, So KF, de Cabo R, Zou S, Ingram DK (2012) Neuroprotection provided by dietary restriction in rats is further enhanced by reducing glucocortocoids. Neurobiol Aging 33(10):2398\u20132410. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.11.025","journal-title":"Neurobiol Aging"},{"issue":"6","key":"2609_CR24","first-page":"1582","volume":"22","author":"ZR Liu","year":"2017","unstructured":"Liu ZR, Sun LZ, Jia TH, Jia DF (2017) beta-Aescin shows potent antiproliferative activity in osteosarcoma cells by inducing autophagy, ROS generation and mitochondrial membrane potential loss. J BUON 22(6):1582\u20131586","journal-title":"J BUON"},{"key":"2609_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.yjmcc.2018.04.009","volume":"119","author":"S Wang","year":"2018","unstructured":"Wang S, Ge W, Harns C, Meng X, Zhang Y, Ren J (2018) Ablation of toll-like receptor 4 attenuates aging-induced myocardial remodeling and contractile dysfunction through NCoRI-HDAC1-mediated regulation of autophagy. J Mol Cell Cardiol 119:40\u201350. \n                    https:\/\/doi.org\/10.1016\/j.yjmcc.2018.04.009","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"2609_CR26","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.freeradbiomed.2011.08.030","volume":"51","author":"L Schneider","year":"2011","unstructured":"Schneider L, Giordano S, Zelickson BR, M SJ, Ouyang GAB, Fineberg X, Darley-Usmar N, Zhang VM J (2011) Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress. Free Radic Biol Med 51(11):2007\u20132017. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.08.030","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"2609_CR27","first-page":"1086","volume":"123","author":"HR Xie","year":"2010","unstructured":"Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin Med J 123(8):1086\u20131092","journal-title":"Chin Med J"},{"issue":"1","key":"2609_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/bcj20170803","volume":"475","author":"Y Fan","year":"2018","unstructured":"Fan Y, Howden AJM, Sarhan AR, Lis P, Ito G, Martinez TN, Brockmann K, Gasser T, Alessi DR, Sammler EM (2018) Interrogating Parkinson\u2019s disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils. Biochem J 475(1):23\u201344. \n                    https:\/\/doi.org\/10.1042\/bcj20170803","journal-title":"Biochem J"},{"issue":"4","key":"2609_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44(4):601\u2013607. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005","journal-title":"Neuron"},{"issue":"7","key":"2609_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.parkreldis.2010.11.008","volume":"17","author":"S Bardien","year":"2011","unstructured":"Bardien S, Lesage S, Brice A, Carr J (2011) Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson\u2019s disease. Parkinsonism Relat Disord 17(7):501\u2013508. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2010.11.008","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2609_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/hmg\/ddv453","volume":"25","author":"NJ Lavalley","year":"2016","unstructured":"Lavalley NJ, Slone SR, Ding H, West AB, Yacoubian TA (2016) 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening. Hum Mol Genet 25(1):109\u2013122. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv453","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2609_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.parkreldis.2009.11.004","volume":"16","author":"L Correia Guedes","year":"2010","unstructured":"Correia Guedes L, Ferreira JJ, Rosa MM, Coelho M, Bonifati V, Sampaio C (2010) Worldwide frequency of G2019S LRRK2 mutation in Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord 16(4):237\u2013242. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2009.11.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"2609_CR33","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1039\/c7fo00991g","volume":"8","author":"G Qi","year":"2017","unstructured":"Qi G, Mi Y, Wang Y, Li R, Huang S, Li X, Liu X (2017) Neuroprotective action of tea polyphenols on oxidative stress-induced apoptosis through the activation of the TrkB\/CREB\/BDNF pathway and Keap1\/Nrf2 signaling pathway in SH-SY5Y cells and mice brain. Food Funct 8(12):4421\u20134432. \n                    https:\/\/doi.org\/10.1039\/c7fo00991g","journal-title":"Food Funct"},{"key":"2609_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/neuro.02.001.2010","volume":"3","author":"C Cunha","year":"2010","unstructured":"Cunha C, Brambilla R, Thomas KL (2010) A simple role for BDNF in learning and memory? Front Mol Neurosci 3:1. \n                    https:\/\/doi.org\/10.3389\/neuro.02.001.2010","journal-title":"Front Mol Neurosci"},{"key":"2609_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000342502","volume":"24","author":"S Ramamoorthy","year":"2013","unstructured":"Ramamoorthy S, Cidlowski JA (2013) Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance. Endocr Dev 24:41\u201356. \n                    https:\/\/doi.org\/10.1159\/000342502","journal-title":"Endocr Dev"},{"key":"2609_CR36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-17-2793","author":"DC West","year":"2018","unstructured":"West DC, Kocherginsky M, Tonsing-Carter EY, Dolcen DN, Hosfield DJ, Lastra RR, Sinnwell JP, Thompson KJ, Bowie KR, Harkless RV, Skor MN, Pierce CF, Styke SC, Kim CR, de Wet L, Greene GL (2018) Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer. Clin Cancer Res. \n                    https:\/\/doi.org\/10.1158\/1078-0432.ccr-17-2793","journal-title":"Clin Cancer Res"},{"key":"2609_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122614","author":"GR Fries","year":"2017","unstructured":"Fries GR, Gassen NC, Rein T (2017) The FKBP51 glucocorticoid receptor co-chaperone: regulation, function, and implications in health and disease. Int J Mol Sci. \n                    https:\/\/doi.org\/10.3390\/ijms18122614","journal-title":"Int J Mol Sci"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-018-2609-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-2609-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-2609-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T03:37:36Z","timestamp":1569037056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-018-2609-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["2609"],"URL":"https:\/\/doi.org\/10.1007\/s11064-018-2609-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"22 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}